PROCTER & GAMBLE Co PG

Healthcare SIC 2840 - Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics NAICS Manufacturing › Chemical Manufacturing › Soap, Cleaning Compound, and Toilet Preparation Manufacturing › Soap and Cleaning Compound Manufacturing derived NYSE

Last close 161.02 2026-10-23
Market cap $374.28B 2026-06-30 share count
52-week range 137.62 - 167.25

Valuation FY2026 figures against the last close

P/S4.3x
P/E24.3x
P/FCF24.7x
EV/EBITDA17.2x
Dividend yield2.7%
Diluted EPS6.62

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • International
  • United States
Revenue by geography, 2 categories over 3 years. The same figures are in the table below. FY2026 International, FY2026: 45.3B (52.1%) 52% International United States, FY2026: 41.7B (47.9%) 48% United States FY2025 International, FY2025: 42.7B (50.7%) 51% United States, FY2025: 41.6B (49.3%) 49% FY2024 International, FY2024: 43.5B (51.8%) 52% United States, FY2024: 40.5B (48.2%) 48%
Region FY2026FY2025FY2024
International $45.30B $42.70B $43.50B
United States $41.70B $41.60B $40.50B

As the company reported it, from the “SEGMENT INFORMATION - US And International Sales And Assets (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Revenue by segment

  • Fabric & Home Care
  • Baby, Feminine & Family Care
  • Beauty
  • Health Care
  • Grooming
Revenue by segment, 5 categories over 3 years. The same figures are in the table below. FY2026 Fabric & Home Care, FY2026: 30.3B (35.2%) 35% Fabric & Home Care Baby, Feminine & Family Care, FY2026: 20.4B (23.7%) 24% Baby, Feminine & Family Care Beauty, FY2026: 16B (18.6%) 19% Beauty Health Care, FY2026: 12.5B (14.5%) 14% Health Care Grooming, FY2026: 6.9B (8.0%) 8% Grooming FY2025 Fabric & Home Care, FY2025: 29.6B (35.5%) 35% Baby, Feminine & Family Care, FY2025: 20.2B (24.3%) 24% Beauty, FY2025: 15B (17.9%) 18% Health Care, FY2025: 12B (14.4%) 14% Grooming, FY2025: 6.7B (8.0%) 8% FY2024 Fabric & Home Care, FY2024: 29.5B (35.3%) 35% Baby, Feminine & Family Care, FY2024: 20.3B (24.3%) 24% Beauty, FY2024: 15.2B (18.2%) 18% Health Care, FY2024: 11.8B (14.1%) 14% Grooming, FY2024: 6.7B (8.0%) 8%
Segment FY2026FY2025FY2024
Fabric & Home Care $30.31B $29.62B $29.50B
Baby, Feminine & Family Care $20.40B $20.25B $20.28B
Beauty $16.02B $14.96B $15.22B
Health Care $12.46B $12.00B $11.79B
Grooming $6.92B $6.66B $6.65B

As the company reported it, from the “SEGMENT INFORMATION - Segment Results (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue $87.03B$84.28B$84.04B$82.01B$80.19B$76.12B$70.95B$67.68B$66.83B$65.06B
Cost of revenue $43.36B$41.16B$40.85B$42.76B$42.16B$37.11B$35.25B$34.77B$34.43B$32.64B
Gross profit $43.67B$43.12B$43.19B$39.25B$38.03B$39.01B$35.70B$32.92B$32.40B$32.42B
R&D $2.10B$2.10B$2.00B$2.00B$2.00B$1.90B$1.80B$1.90B$1.90B$1.90B
SG&A $23.92B$22.67B$23.30B$21.11B$20.22B$21.02B$19.99B$19.08B$19.04B$18.65B
Operating income $19.75B$20.45B$18.55B$18.13B$17.81B$17.99B$15.71B$5.49B$13.36B$13.77B
Interest expense $877.0M$907.0M$925.0M$756.0M$439.0M$502.0M$465.0M$509.0M$506.0M$465.0M
Pre-tax income $20.38B$20.17B$18.76B$18.35B$18.00B$17.57B$15.76B$6.00B$13.21B$18.39B
Income tax $4.23B$4.10B$3.79B$3.62B$3.20B$3.26B$2.73B$2.10B$3.46B$3.06B
Net income $16.10B$16.10B$15.00B$14.70B$14.80B$14.31B$13.03B$3.90B$9.75B$15.33B
EPS, basic 6.756.676.186.076.005.695.131.453.755.80
EPS, diluted 6.626.516.025.905.815.504.961.433.675.59
Shares, diluted (wtd. avg.) 2.42B2.45B2.47B2.48B2.54B2.60B2.63B2.54B2.66B2.74B

Balance sheet

Fiscal year FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents $9.94B$9.56B$9.48B$8.25B$7.21B$10.29B$16.18B$4.24B$2.57B$5.57B
Receivables $6.06B$6.18B$6.12B$5.47B$5.14B$4.72B$4.18B$4.95B$4.69B$4.59B
Inventory $8.17B$7.55B$7.02B$7.07B$6.92B$5.98B$5.50B$5.02B$4.74B$4.62B
Total current assets $26.21B$25.39B$24.71B$22.65B$21.65B$23.09B$27.99B$22.47B$23.32B$26.49B
Property, plant and equipment $25.36B$23.90B$22.15B$21.91B$21.20B$21.69B$20.69B$21.27B$20.60B$19.89B
Goodwill $41.28B$41.65B$40.30B$40.66B$39.70B$40.92B$39.90B$40.27B$45.17B$44.70B
Other intangibles $21.44B$21.91B$22.05B$23.78B$23.68B$23.64B$23.79B$24.21B$23.90B$24.19B
Total assets $126.52B$125.23B$122.37B$120.83B$117.21B$119.31B$120.70B$115.09B$118.31B$120.41B
Accounts payable $16.31B$15.23B$15.36B$14.60B$14.88B$13.72B$12.07B$11.26B$10.34B$9.63B
Short-term debt $6.46B$5.38B$3.84B$3.95B$3.65B$3.62B$2.51B$3.39B$1.77B$1.68B
Total current liabilities $38.69B$36.06B$33.63B$35.76B$33.08B$33.13B$32.98B$30.01B$28.24B$30.21B
Long-term debt $22.84B$25.00B$25.27B$24.38B$22.85B$23.10B$23.54B$20.39B$20.86B$18.04B
Total liabilities $72.21B$72.95B$71.81B$73.76B$70.35B$72.65B$73.82B$67.52B$65.43B$64.63B
Retained earnings $135.85B$129.97B$123.81B$118.17B$112.43B$106.37B$100.24B$94.92B$98.64B$96.12B
Total equity $54.31B$52.28B$50.56B$47.06B$46.85B$46.65B$46.88B$47.58B$52.88B$55.78B

Cash flow

Fiscal year FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating cash flow $19.56B$17.82B$19.85B$16.85B$16.72B$18.37B$17.40B$15.24B$14.87B$12.75B
Depreciation and amortisation $3.16B$2.85B$2.90B$2.71B$2.81B$2.73B$3.01B$2.82B$2.83B$2.82B
Stock-based compensation $524.0M$476.0M$562.0M$545.0M$528.0M$540.0M$558.0M$515.0M$395.0M$351.0M
Capital expenditure $4.41B$3.77B$3.32B$3.06B$3.16B$2.79B$3.07B$3.35B$3.72B$3.38B
Investing cash flow -$4.62B-$3.82B-$3.50B-$3.50B-$4.42B-$2.83B$3.04B-$3.49B-$3.51B-$6.68B
Financing cash flow -$14.46B-$14.04B-$14.86B-$12.15B-$14.88B-$21.53B-$8.37B-$9.99B-$14.38B-$8.57B
Dividends paid $10.23B$9.87B$9.31B$9.00B$8.77B$8.26B$7.79B$7.50B$7.31B$7.24B
Buybacks $5.03B$6.50B$5.01B$7.35B$10.00B$11.01B$7.41B$5.00B$7.00B$5.20B

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-372211.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 25B 50B 75B 100B Revenue, FY2017: 65.1B Gross profit, FY2017: 32.4B Net income, FY2017: 15.3B Revenue, FY2018: 66.8B Gross profit, FY2018: 32.4B Net income, FY2018: 9.8B Revenue, FY2019: 67.7B Gross profit, FY2019: 32.9B Net income, FY2019: 3.9B Revenue, FY2020: 71B Gross profit, FY2020: 35.7B Net income, FY2020: 13B Revenue, FY2021: 76.1B Gross profit, FY2021: 39B Net income, FY2021: 14.3B Revenue, FY2022: 80.2B Gross profit, FY2022: 38B Net income, FY2022: 14.8B Revenue, FY2023: 82B Gross profit, FY2023: 39.2B Net income, FY2023: 14.7B Revenue, FY2024: 84B Gross profit, FY2024: 43.2B Net income, FY2024: 15B Revenue, FY2025: 84.3B Gross profit, FY2025: 43.1B Net income, FY2025: 16.1B Revenue, FY2026: 87B Gross profit, FY2026: 43.7B Net income, FY2026: 16.1B FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025 FY2026
Fiscal year FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue $65.06B $66.83B $67.68B $70.95B $76.12B $80.19B $82.01B $84.04B $84.28B $87.03B
Gross profit $32.42B $32.40B $32.92B $35.70B $39.01B $38.03B $39.25B $43.19B $43.12B $43.67B
Net income $15.33B $9.75B $3.90B $13.03B $14.31B $14.80B $14.70B $15.00B $16.10B $16.10B

Recent filings and events

  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2840

TickerCompanyMarket capP/ERevenue growth
ECL ECOLAB INC. $80.88B 39.6x 2.2%
CHD CHURCH & DWIGHT CO INC /DE/ $24.95B 34.8x 1.6%
SCL STEPAN CO $1.45B 31.2x 7.0%
UL UNILEVER PLC — — —
WNW Meiwu Technology Co Ltd — — 4,368.0%
BYAH Park Ha Biological Technology Co., Ltd. — — 6.0%